UNSPSC 51293901: Oxabrexine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51293901

Definition

This classification denotes a mucolytic agent and antitussive agent with the molecular formula C18H25Br2NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F220MU498K, chemically known as ethyl-((4,6-dibromo-alpha-(cyclohexylmethylamino)-o-tolyl)oxy)acetate but generally known as oxabrexine, which bears US NIH Compound Identifier 167463. European Medicines Agency schedules Oxabrexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09482MIG.

Read the full definition

The term OXABREXINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). OXABREXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxabrexine under HS 29222900 and SITC 51462. As of Q4 2014, OXABREXINE remains the US FDA Preferred Term for this commodity. Oxabrexine bears US NLM identifiers UMLS ID C2983807 and NCI Concept Code C90624. SMILES: Brc1c(OCC(=O)OCC)c(CN(C2CCCCC2)C)cc(Br)c1.

About UNSPSC 51293901

UNSPSC 51293901 Oxabrexine is a Commodity code tracking pharmaceutical products used in emergency medical response and public health interventions, specifically opioid-antagonist medications and associated drug-disposal systems procured by state and local health departments and county governments. State and local agencies soliciting under this code are acquiring naloxone (Narcan) and safe drug deactivation systems to support overdose-response and community health initiatives, typically through competitive bidding processes with quarterly or recurring delivery schedules. The work involves supplying finished pharmaceutical inventory and complementary disposal equipment to county health facilities, with vendors responsible for logistics, storage compliance, and adherence to federal and state pharmaceutical handling regulations.

Seminole County, Florida represents the clearest recent activity under this code. In an IFB posted June 30, 2026 with response due July 26, 2023, Seminole County sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement calls for fixed-fee pricing with delivery costs included, a two-year initial term plus one-year renewal option, and compliance with E-Verify, drug-free workplace certification, workers' compensation and professional liability insurance, and federal environmental regulations tied to potential FEMA funding. The contract includes a three-month probationary termination clause and requires vendors to be legally authorized to work in the United States. Beyond the Seminole County opportunity, the source does not identify additional recent state or local solicitations under this code, making geographic and issuing-body characterization limited to this single posted opportunity.

Quick answers

What is UNSPSC 51293901?

UNSPSC 51293901 is Oxabrexine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51293901?

UNSPSC 51293901 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51293901

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code